StockDrifts LogoStockDrifts

Tea Vaccine Research Institute 261780

Company
차백신연구소Tea Vaccine Research Institute
Insiders
2
Buys
1
Total Value
₩75M ($52K)
Avg Return
+9.49%
Last Filing
2026-04-30

Tea Vaccine Research Institute (261780) has 1 disclosed insider purchases and 1 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩75M ($52K) in reported transaction value. The earliest filing StockDrifts holds for Tea Vaccine Research Institute is dated 2024-03-29; the most recent is 2026-04-30. Across these filings the average return since disclosure is +9.49%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-04-30SELL장외매도
차바이오텍
CHA Biotech
--8.9M₩4,100-8.9%₩36.7B ($25.5M)
2026-03-26SELLMarket Sell
고정재
fixing material
Internal director-14.3K₩4,530+22.1%₩65M ($45K)
2025-09-25BUYMarket Buy
HAN SEUNGIL
CEO3.7K₩2,735-3.1%₩10M ($7K)
2025-04-01BUY주식매수선택권
고정재
fixing material
Internal director26.7K₩2,830-6.4%₩75M ($52K)
2024-03-29BUY주식매수선택권
조정기
regulator
president50.0K₩5,140-48.4%₩257M ($178K)
2024-03-29BUY주식매수선택권
고정재
fixing material
Internal director26.7K₩5,140-48.4%₩137M ($95K)

Frequently asked questions

Who has been buying Tea Vaccine Research Institute stock?
2 distinct insiders have filed 1 disclosed insider purchases in Tea Vaccine Research Institute (261780), most recently on 2026-04-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Tea Vaccine Research Institute have?
Tea Vaccine Research Institute has 1 buy-side and 1 sell-side disclosures on record, covering ₩75M ($52K) in total reported value, spanning 2024-03-29 to 2026-04-30.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.